Potential Impact of Prenatal Expanded Carrier Screening on the Incidence of Duchenne Muscular Dystrophy in Neonates

With increasing uptake of prenatal maternal genetic screening, in conjunction with continuing expansion of gene lists for rare disorders, it is suggested that rare disorder incidence may decrease over time, either by avoiding an affected pregnancy with the help of artificial reproductive technology or pregnancy termination when prenatal diagnosis is initiated by ECS.